Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy
Clinical trial NCT04579133 · TERMINATED
Trial details
- NCT number
- NCT04579133
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-03-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.